Document is current

Any future updates will be listed below

Correction to: Effcacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study

Crossref DOI link: https://doi.org/10.1007/s12325-024-03059-6

Published Online: 2024-11-09

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark